FAB-144
![]() | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H27FN2O |
| Molar mass | 330.447 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
FAB-144 is an indazole-based synthetic cannabinoid that is presumed to be a potent agonist of the CB1 receptor[1] and has been sold online as a designer drug.[2] It is the indazole analogue of XLR-11.
Legal status
Sweden's public health agency suggested classifying FAB-144 as a hazardous substance on November 10, 2014.[3]
See also
References
- ^ Hess C, Schoeder CT, Pillaiyar T, Madea B, Müller CE (2016). "Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice". Forensic Toxicology. 34: 329–343. doi:10.1007/s11419-016-0320-2. PMC 4929166. PMID 27429655.
- ^ "FAB-144". Cayman Chemical. Retrieved 23 July 2015.
- ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Folkhälsomyndigheten. Retrieved 23 July 2015.
